To determine whether PDT and TI/PDT altered other aspects of the immune environment that might indirectly affect CD8+ T-cell activity, we performed another Winn assay using the whole spleen digest (splenocytes) mixed with tumor cells. The gene discussed is CD8A; the disease is neoplasm.